Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by prophetoffactzon Jan 20, 2023 3:32pm
101 Views
Post# 35236350

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2-million-dollar fee

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2-million-dollar fee"...others here are emotional over charged with anger blinding them to the reality of this situation."

It's unfortunate but I think some people overcommitted to a single speculative asset. They have been so hurt that they've made their investment today all about themselves. It is about what they need to get back to breakeven and not a clear focus on doing what is right for the business. What is best for the business doesn't necessarily care about what they need to breakeven. 

If people only invested in a given stock an amount whereby they never thought about what they needed to breakeven again, but instead clearly focused on what is best for the business they could be able to keep a clear mind. In the end they would have a portfolio of stocks where they are focused on the buisness and can more freely adjust to the dynamics of time. Business is often very painful; and being controlled by that pain of an investment can be devastating. BTI's history is one of never doing what is right and neccesary for the business and today is the result. BTI hit bottom and was forced to re-set. If BTI could take on more debt to create an illusion of no immediate dilution, and spend another decade living a hand-to-mouth financial existence in permanent financial emergency, where the business never advanced but you avoided the immediate dilution some would. 



"A sunk cost is any cost that’s already been invested and can’t be retrieved. The sunk cost fallacy (sometimes called the lost cost fallacy or trap) is a cognitive bias that causes people to stick with a plan, course, or approach that isn’t working because of how much has already been invested in it. Investment here can mean money, time, effort, or all three."
<< Previous
Bullboard Posts
Next >>